Dr Nazia Chaudhuri

Consultant Respiratory Physician, Clinical Lead in ILD, Deputy Clinical Director Respiratory
Manchester University FT

Dr Nazia Chaudhuri is a respiratory physician and the clinical lead for the interstitial lung disease (ILD) service at the Manchester University NHS Foundation Trust (MFT), United Kingdom. She is an honorary Senior lecturer at the University of Manchester. She is also deputy Clinical Director of the respiratory directorate at MFT.

The MFT ILD tertiary service has established itself as one of the largest ILD units in the UK delivering exemplary care to over 900 new patients per year. She is the clinical lead of a growing team consisting of five consultant colleagues, a clinical fellow, three ILD Specialist nurses, an ILD pharmacist and a multi-disciplinary team (MDT) co-ordinator.

She graduated from the University of Leeds with an honours degree in medicine and a BSc honours in genetics. She performed a PhD and published her work looking at the cellular interactions and signalling in response to infection and air pollution.

As an ILD specialist, Dr Chaudhuri has developed the local ILD service by enhancing the delivery of care by establishing day case model to reduce waiting times, creating a clinical database and ensuring a presence on the internet by developing a website, twitter and Facebook page. She has been instrumental in setting up and delivering a regional North West and Northern ILD network.

She is the principal investigator on a number of clinical research trials in idiopathic pulmonary fibrosis (IPF) and is the UK Chief Investigator of a major clinical trial on progressive ILDs. She is also co-applicant for a British Lung foundation grant for a study in Sarcoidosis.

Dr Chaudhuri has published her experience in prescribing antifibrotics and delivering MDT care and has presented over 30 abstracts pertaining to IPF, antifibrotics and the importance of a multi-disciplinary team approach at all major respiratory conferences. She is a member of the British Thoracic Society (BTS) lung registry steering group for the BTS sarcoid and IPF registry. She has been instrumental in ensuring that MFT is the biggest contributor to the BTS IPF Registry. She is also a medical adviser for the British Lung Foundation.